CLARUS THERAPEUTICS HOLDINGS (CRXT)
US18271L1070 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to CRXT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 2990.91% above the current price.
CRXT was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CRXT.
In the previous month the buy percentage consensus was at a similar level.
CRXT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-23 | Needham | Downgrade | Buy -> Hold |
| 2022-08-22 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-05-17 | Needham | Maintains | Buy |
| 2022-05-17 | Truist Securities | Maintains | Buy |
| 2021-10-13 | Truist Securities | Initiate | Buy |
| 2021-10-06 | Needham | Initiate | Buy |
| 2021-09-29 | Maxim Group | Initiate | Buy |
| 2021-09-20 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-09-20 | Oppenheimer | Initiate | Outperform |